BamSEC and AlphaSense Join Forces
Learn More

Cidara Therapeutics Inc.

NASDAQ: CDTX    
Share price (8/15/25): $65.22    
Market cap (8/15/25): $1.654 billion
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 1 page Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Cidara Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Cidara Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 13 pages Cidara Therapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series a Convertible Voting Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.2
from 10-K 1 page Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Cidara Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 12 pages Series X Convertible Preferred Stock
12/34/56
EX-3.2
from 8-K 25 pages Amended and Restated Bylaws of Cidara Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 6 pages Amended and Restated Certificate of Incorporation of Cidara Therapeutics, Inc
12/34/56
EX-3.4
from S-1 25 pages Amended and Restated Bylaws of Cidara Therapeutics, Inc
12/34/56
EX-3.3
from S-1 18 pages Amended and Restated By-Laws of K2 Therapeutics, Inc
12/34/56
EX-3.2
from S-1 6 pages Amended and Restated Certificate of Incorporation of Cidara Therapeutics, Inc
12/34/56
EX-3.1
from S-1 21 pages Second Amended and Restated Certificate of Incorporation of Cidara Therapeutics, Inc
12/34/56
EX-3
from DRS 18 pages Amended and Restated By-Laws of K2 Therapeutics, Inc
12/34/56
EX-3
from DRS 21 pages Amended and Restated Certificate of Incorporation of K2 Therapeutics, Inc
12/34/56